<?xml version="1.0" encoding="UTF-8"?>
<drug type="small molecule" created="2015-11-26" updated="2019-12-02">
  <drugbank-id primary="true">DB09336</drugbank-id>
  <name>Technetium Tc-99m nofetumomab merpentan</name>
  <description>Technetium Tc-99m nofetumomab merpentan (Tc-99m nm) consists of a Fab fragment of an IgG2b of the pancarcinoma murine antibody NR-LU-10.[A32115] The NR-LU-10 antibody is directed against a 40 kDa glycoprotein antigen expressed in a variety of cancers and some normal tissues.[FDA label] Tc-99m nm was developed by Boehringer Ingelheim Pharma KG and FDA approved on September 14, 1992. It was after discontinued on August 13, 2013, but in the 2018 FDA submission list, it can be found as a substance type II (Drug substance) with an active status.[L1650, L1082]</description>
  <cas-number>165942-79-0</cas-number>
  <unii>9UFH75HT7S</unii>
  <state>solid</state>
  <groups>
    <group>approved</group>
    <group>withdrawn</group>
  </groups>
  <general-references>
    <articles>
      <article>
        <ref-id>A32115</ref-id>
        <pubmed-id>9298295</pubmed-id>
        <citation>Breitz HB, Tyler A, Bjorn MJ, Lesley T, Weiden PL: Clinical experience with Tc-99m nofetumomab merpentan (Verluma) radioimmunoscintigraphy. Clin Nucl Med. 1997 Sep;22(9):615-20.</citation>
      </article>
    </articles>
    <textbooks>
      <textbook>
        <ref-id>T126</ref-id>
        <isbn/>
        <citation>Honjo T., Alt F. and Neuberger M. (2004). Molecular biology of B cells. Elsevier .</citation>
      </textbook>
    </textbooks>
    <links>
      <link>
        <ref-id>L1146</ref-id>
        <title>Technetium radiopharmaceutical chemistry</title>
        <url>https://pdfs.semanticscholar.org/bfa5/c1913650a8a23b0359c3d9d2f5710a243a27.pdf</url>
      </link>
      <link>
        <ref-id>L1651</ref-id>
        <title>Cancer</title>
        <url>https://www.cancer.org/cancer/small-cell-lung-cancer/about/what-is-small-cell-lung-cancer.html</url>
      </link>
      <link>
        <ref-id>L1652</ref-id>
        <title>Pharmacopeia</title>
        <url>http://www.pharmacopeia.cn/v29240/usp29nf24s0_m80698.html</url>
      </link>
      <link>
        <ref-id>L1667</ref-id>
        <title>Pharmacological science</title>
        <url>https://www.pharmacologicalsciences.us/pharmaceutical-chemistry/monoclonal-antibody-radionuclide-test-kits.html</url>
      </link>
      <link>
        <ref-id>L1668</ref-id>
        <title>National Public library</title>
        <url>http://www.nationalpubliclibrary.info/articles/eng/Technetium_(99mTc)_nofetumomab_merpentan</url>
      </link>
      <link>
        <ref-id>L1650</ref-id>
        <title>FDA CDER list</title>
        <url>https://www.fda.gov/downloads/forindustry/userfees/prescriptiondruguserfee/ucm164641.pdf</url>
      </link>
      <link>
        <ref-id>L1082</ref-id>
        <title>FDA Submission</title>
        <url>https://www.fda.gov/downloads/drugs/developmentapprovalprocess/formssubmissionrequirements/drugmasterfilesdmfs/ucm370723.txt</url>
      </link>
    </links>
    <attachments/>
  </general-references>
  <synthesis-reference/>
  <indication>Tc-99m nm is one of the technetium-labeled antibodies and it is indicated for the detection of small-cell lung cancer.[L1146] The small cell lung cancer is a syndrome characterized by the abnormal and uncontrolled cell growth and it is characterized by a shorter doubling time, higher growth fraction and earlier development of metastases.[L1651]</indication>
  <pharmacodynamics>Studies have shown that the Fab fragment presents high immunoreactivity in small cell lung cancer tumors. The adenocarcinomas of the kidney and pancreas are not detected. This lack of diagnostic detection can be explained because some radioactivity gets accumulated in the excretion pathway, in nonspecific vascular locations and in non-tumor areas with traces of inflammation, increased vascular pool or recent surgical. Therefore, the detection rate may be reduced in those areas and its adjacent zones.[FDA Label]</pharmacodynamics>
  <mechanism-of-action>The mechanism of action in Tc-99m nm is ruled by the presence of nofetumomab, which can recognize the pancarcinoma antigen EpCAM and/or CD20/MS4A1,[T126] and merpentan, that acts as a linker for the binding of technetium.[L1667]</mechanism-of-action>
  <toxicity>Long-term preclinical studies to determine the carcinogenic, mutagenic or fertility effect have not been studied.[FDA label]</toxicity>
  <metabolism/>
  <absorption>After intravenous administration, Tc-99m nm presents a rapid distribution phase.[FDA label]</absorption>
  <half-life>The radioactive half-life of the Tc-99m nm is of 6 hours. It is important to consider this short half-life as the use of this agent should be done within the active time.[L1652] Tc-99m nm presents a serum half-life of 1.5 hours and an elimination phase half-life of 10.5 hours.[L1668]</half-life>
  <protein-binding>There are no reports of binding of Tc-99m nm to binding proteins.[FDA label]</protein-binding>
  <route-of-elimination>The primary route of elimination is renal and accounts for the 64% of the administered dose. After renal clearance, the main route is hepatobiliary. All the different elimination pathways lead to accumulation of radioactivity on the kidney, urinary bladder, gall bladder and intestines.[L1668]</route-of-elimination>
  <volume-of-distribution/>
  <clearance/>
  <salts/>
  <synonyms>
    <synonym language="english" coder="">Nofetumomab</synonym>
    <synonym language="english" coder="">Technetium (99mTc) nofetumomab merpentan</synonym>
    <synonym language="english" coder="">Technetium Tc 99m nofetumomab merpentan</synonym>
  </synonyms>
  <products/>
  <international-brands/>
  <mixtures/>
  <packagers/>
  <manufacturers/>
  <prices/>
  <categories/>
  <affected-organisms>
    <affected-organism>Humans and other mammals</affected-organism>
  </affected-organisms>
  <dosages/>
  <atc-codes/>
  <ahfs-codes/>
  <pdb-entries/>
  <fda-label>//s3-us-west-2.amazonaws.com/drugbank/fda_labels/DB09336.pdf?1520970435</fda-label>
  <patents/>
  <food-interactions/>
  <drug-interactions/>
  <calculated-properties/>
  <experimental-properties>
    <property>
      <kind>Radioactivity</kind>
      <value>30</value>
      <source>FDA label</source>
    </property>
  </experimental-properties>
  <external-identifiers>
    <external-identifier>
      <resource>PubChem Substance</resource>
      <identifier>347910442</identifier>
    </external-identifier>
  </external-identifiers>
  <external-links/>
  <pathways/>
  <reactions/>
  <snp-effects/>
  <snp-adverse-drug-reactions/>
  <targets>
    <target position="1">
      <id>BE0002446</id>
      <name>Epithelial cell adhesion molecule</name>
      <organism>Humans</organism>
      <actions>
        <action>binder</action>
      </actions>
      <references>
        <articles/>
        <textbooks>
          <textbook>
            <ref-id>T126</ref-id>
            <isbn/>
            <citation>Honjo T., Alt F. and Neuberger M. (2004). Molecular biology of B cells. Elsevier .</citation>
          </textbook>
        </textbooks>
        <links/>
        <attachments/>
      </references>
      <known-action>yes</known-action>
      <polypeptide id="P16422" source="Swiss-Prot">
        <name>Epithelial cell adhesion molecule</name>
        <general-function>Protein complex binding</general-function>
        <specific-function>May act as a physical homophilic interaction molecule between intestinal epithelial cells (IECs) and intraepithelial lymphocytes (IELs) at the mucosal epithelium for providing immunological barrier as a first line of defense against mucosal infection. Plays a role in embryonic stem cells proliferation and differentiation. Up-regulates the expression of FABP5, MYC and cyclins A and E.</specific-function>
        <gene-name>EPCAM</gene-name>
        <locus>2p21</locus>
        <cellular-location>Lateral cell membrane</cellular-location>
        <transmembrane-regions>266-288</transmembrane-regions>
        <signal-regions>1-23</signal-regions>
        <theoretical-pi>7.53</theoretical-pi>
        <molecular-weight>34932.005</molecular-weight>
        <chromosome-location>2</chromosome-location>
        <organism ncbi-taxonomy-id="9606">Humans</organism>
        <external-identifiers>
          <external-identifier>
            <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
            <identifier>HGNC:11529</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenAtlas</resource>
            <identifier>TACSTD1</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>M32325</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>P16422</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>EPCAM_HUMAN</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>Adenocarcinoma-associated antigen</synonym>
          <synonym>Cell surface glycoprotein Trop-1</synonym>
          <synonym>EGP</synonym>
          <synonym>EGP314</synonym>
          <synonym>Ep-CAM</synonym>
          <synonym>Epithelial cell surface antigen</synonym>
          <synonym>Epithelial glycoprotein</synonym>
          <synonym>Epithelial glycoprotein 314</synonym>
          <synonym>GA733-2</synonym>
          <synonym>hEGP314</synonym>
          <synonym>KS 1/4 antigen</synonym>
          <synonym>KSA</synonym>
          <synonym>M1S2</synonym>
          <synonym>M4S1</synonym>
          <synonym>Major gastrointestinal tumor-associated protein GA733-2</synonym>
          <synonym>MIC18</synonym>
          <synonym>TACSTD1</synonym>
          <synonym>TROP1</synonym>
          <synonym>Tumor-associated calcium signal transducer 1</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0016791|Epithelial cell adhesion molecule
MAPPQVLAFGLLLAAATATFAAAQEECVCENYKLAVNCFVNNNRQCQCTSVGAQNTVICS
KLAAKCLVMKAEMNGSKLGRRAKPEGALQNNDGLYDPDCDESGLFKAKQCNGTSMCWCVN
TAGVRRTDKDTEITCSERVRTYWIIIELKHKAREKPYDSKSLRTALQKEITTRYQLDPKF
ITSILYENNVITIDLVQNSSQKTQNDVDIADVAYYFEKDVKGESLFHSKKMDLTVNGEQL
DLDPGQTLIYYVDEKAPEFSMQGLKAGVIAVIVVVVIAVVAGIVVLVISRKKRMAKYEKA
EIKEMGEMHRELNA</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0016792|Epithelial cell adhesion molecule (EPCAM)
ATGGCGCCCCCGCAGGTCCTCGCGTTCGGGCTTCTGCTTGCCGCGGCGACGGCGACTTTT
GCCGCAGCTCAGGAAGAATGTGTCTGTGAAAACTACAAGCTGGCCGTAAACTGCTTTGTG
AATAATAATCGTCAATGCCAGTGTACTTCAGTTGGTGCACAAAATACTGTCATTTGCTCA
AAGCTGGCTGCCAAATGTTTGGTGATGAAGGCAGAAATGAATGGCTCAAAACTTGGGAGA
AGAGCAAAACCTGAAGGGGCCCTCCAGAACAATGATGGGCTTTATGATCCTGACTGCGAT
GAGAGCGGGCTCTTTAAGGCCAAGCAGTGCAACGGCACCTCCATGTGCTGGTGTGTGAAC
ACTGCTGGGGTCAGAAGAACAGACAAGGACACTGAAATAACCTGCTCTGAGCGAGTGAGA
ACCTACTGGATCATCATTGAACTAAAACACAAAGCAAGAGAAAAACCTTATGATAGTAAA
AGTTTGCGGACTGCACTTCAGAAGGAGATCACAACGCGTTATCAACTGGATCCAAAATTT
ATCACGAGTATTTTGTATGAGAATAATGTTATCACTATTGATCTGGTTCAAAATTCTTCT
CAAAAAACTCAGAATGATGTGGACATAGCTGATGTGGCTTATTATTTTGAAAAAGATGTT
AAAGGTGAATCCTTGTTTCATTCTAAGAAAATGGACCTGACAGTAAATGGGGAACAACTG
GATCTGGATCCTGGTCAAACTTTAATTTATTATGTTGATGAAAAAGCACCTGAATTCTCA
ATGCAGGGTCTAAAAGCTGGTGTTATTGCTGTTATTGTGGTTGTGGTGATAGCAGTTGTT
GCTGGAATTGTTGTGCTGGTTATTTCCAGAAAGAAGAGAATGGCAAAGTATGAGAAGGCT
GAGATAAAGGAGATGGGTGAGATGCATAGGGAACTCAATGCATAA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF00086</identifier>
            <name>Thyroglobulin_1</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>apical plasma membrane</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>basolateral plasma membrane</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>bicellular tight junction</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>cell surface</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>extracellular exosome</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>integral component of membrane</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>lateral plasma membrane</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>plasma membrane</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>protein complex binding</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cell-cell adhesion</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>negative regulation of apoptotic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>negative regulation of cell-cell adhesion mediated by cadherin</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of cell motility</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of cell proliferation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of stem cell proliferation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of transcription from RNA polymerase II promoter</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>signal transduction involved in regulation of gene expression</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>stem cell differentiation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>ureteric bud development</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target position="2">
      <id>BE0000066</id>
      <name>B-lymphocyte antigen CD20</name>
      <organism>Humans</organism>
      <actions>
        <action>binder</action>
      </actions>
      <references>
        <articles/>
        <textbooks>
          <textbook>
            <ref-id>T126</ref-id>
            <isbn/>
            <citation>Honjo T., Alt F. and Neuberger M. (2004). Molecular biology of B cells. Elsevier .</citation>
          </textbook>
        </textbooks>
        <links/>
        <attachments/>
      </references>
      <known-action>yes</known-action>
      <polypeptide id="P11836" source="Swiss-Prot">
        <name>B-lymphocyte antigen CD20</name>
        <general-function>Mhc class ii protein complex binding</general-function>
        <specific-function>This protein may be involved in the regulation of B-cell activation and proliferation.</specific-function>
        <gene-name>MS4A1</gene-name>
        <locus>11q12</locus>
        <cellular-location>Cell membrane</cellular-location>
        <transmembrane-regions>57-78
85-105
121-141
189-209</transmembrane-regions>
        <signal-regions/>
        <theoretical-pi>4.73</theoretical-pi>
        <molecular-weight>33076.99</molecular-weight>
        <chromosome-location>11</chromosome-location>
        <organism ncbi-taxonomy-id="9606">Humans</organism>
        <external-identifiers>
          <external-identifier>
            <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
            <identifier>HGNC:7315</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenAtlas</resource>
            <identifier>MS4A1</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>X12530</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Protein Database</resource>
            <identifier>29774</identifier>
          </external-identifier>
          <external-identifier>
            <resource>Guide to Pharmacology</resource>
            <identifier>2628</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>P11836</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>CD20_HUMAN</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>B-lymphocyte surface antigen B1</synonym>
          <synonym>Bp35</synonym>
          <synonym>CD20</synonym>
          <synonym>Leukocyte surface antigen Leu-16</synonym>
          <synonym>Membrane-spanning 4-domains subfamily A member 1</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0000132|B-lymphocyte antigen CD20
MTTPRNSVNGTFPAEPMKGPIAMQSGPKPLFRRMSSLVGPTQSFFMRESKTLGAVQIMNG
LFHIALGGLLMIPAGIYAPICVTVWYPLWGGIMYIISGSLLAATEKNSRKCLVKGKMIMN
SLSLFAAISGMILSIMDILNIKISHFLKMESLNFIRAHTPYINIYNCEPANPSEKNSPST
QYCYSIQSLFLGILSVMLIFAFFQELVIAGIVENEWKRTCSRPKSNIVLLSAEEKKEQTI
EIKEEVVGLTETSSQPKNEEDIEIIPIQEEEEEETETNFPEPPQDQESSPIENDSSP</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0009913|B-lymphocyte antigen CD20 (MS4A1)
ATGACAACACCCAGAAATTCAGTAAATGGGACTTTCCCGGCAGAGCCAATGAAAGGCCCT
ATTGCTATGCAATCTGGTCCAAAACCACTCTTCAGGAGGATGTCTTCACTGGTGGGCCCC
ACGCAAAGCTTCTTCATGAGGGAATCTAAGACTTTGGGGGCTGTCCAGATTATGAATGGG
CTCTTCCACATTGCCCTGGGGGGTCTTCTGATGATCCCAGCAGGGATCTATGCACCCATC
TGTGTGACTGTGTGGTACCCTCTCTGGGGAGGCATTATGTATATTATTTCCGGATCACTC
CTGGCAGCAACGGAGAAAAACTCCAGGAAGTGTTTGGTCAAAGGAAAAATGATAATGAAT
TCATTGAGCCTCTTTGCTGCCATTTCTGGAATGATTCTTTCAATCATGGACATACTTAAT
ATTAAAATTTCCCATTTTTTAAAAATGGAGAGTCTGAATTTTATTAGAGCTCACACACCA
TATATTAACATATACAACTGTGAACCAGCTAATCCCTCTGAGAAAAACTCCCCATCTACC
CAATACTGTTACAGCATACAATCTCTGTTCTTGGGCATTTTGTCAGTGATGCTGATCTTT
GCCTTCTTCCAGGAACTTGTAATAGCTGGCATCGTTGAGAATGAATGGAAAAGAACGTGC
TCCAGACCCAAATCTAACATAGTTCTCCTGTCAGCAGAAGAAAAAAAAGAACAGACTATT
GAAATAAAAGAAGAAGTGGTTGGGCTAACTGAAACATCTTCCCAACCAAAGAATGAAGAA
GACATTGAAATTATTCCAATCCAAGAAGAGGAAGAAGAAGAAACAGAGACGAACTTTCCA
GAACCTCCCCAAGATCAGGAATCCTCACCAATAGAAAATGACAGCTCTCCTTAA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF04103</identifier>
            <name>CD20</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>external side of plasma membrane</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>extracellular exosome</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>extracellular space</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>integral component of plasma membrane</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>MHC class II protein complex binding</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>B cell proliferation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>humoral immune response</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
  </targets>
  <enzymes/>
  <carriers/>
  <transporters/>
</drug>